More Than a Quarter of Respondents Don’t Want Covid-19 Vaccine

Before the arrival of the first batch of COVID 19 vaccine in Aden on 31st March 2021, ADVISAL Consulting and Research surveyed 136 respondents from ten governorates in Yemen. The results found that more than a quarter of respondents don’t plan to take the vaccine once available.  The online survey covered adult males and females working in government institutions, the private sector, local and international NGOs, and UN agencies in Yemen. The respondents were from Sana’a, Amanat Al Asimah, Ibb, Al Baydha, Hadramout, Shabwah, Raymah, Sa’adah, Hajjah, and Taizz governorates.

Respondents per governorate

Respondents work

Given the split of the Yemeni government, the larger number of suspected cases and deaths than so far reported, the cripple health system in the country, the little capacity to test suspected cases, and misinformation and beliefs of COVID 19 and its vaccine in Yemeni communities, questions arose about community acceptance to COVID 19 vaccine. The results in this survey, to some extent, gave an overview about the challenges actors may face to ensure successful vaccination programs.

The analysis of the collected data showed that 29% of the respondents will not take COVID 19 vaccine, mainly because they do not trust the safety of the trial versions and the potential side effects.

Surprisingly, respondents from rural areas showed more acceptance of the vaccine than those living in urban areas, as shown in the figure below. When analyzing the questions related to respondents’ knowledge about the vaccine and following its news, it was concluded that hesitancy was more prevalent among those who follow the vaccine news. Respondents were asked to rate the vaccine’s safety on a scale from 0 to 10, where 0 is the most unsafe and 10 is the safest. 23% of respondents rated the vaccine from 0 to 4, 59% rated it from 5 to 7, and only 18% rated it from 8 to 10. The average rating among those who follow the vaccine news was only 5.7.

Willingness to take the vaccine

According to these results, actors may need to adopt different approaches and increase awareness efforts in urban areas more than in rural areas. Despite understanding the risk and impact of COVID 19 by almost all respondents, still, hesitancy towards the vaccine was very significant. The survey also spotted differences in hesitancy towards the vaccine, as respondents who were not going to take the vaccine were 29% males and 25% females. Analyzing the answers for why the respondents are not willing to take the vaccine showed that 85% of them think that the vaccine is not safe, while 21% don’t trust the storage capacity of Yemeni facilities to store the vaccine safely, and 4% link the vaccine to conspiracy beliefs and theories.

The survey also measured employees’ acceptance of the vaccine in case it arrived at their workplace. According to the results, 62% of respondents are willing to take the vaccine and encourage others to take it, 25% will take it and will not interfere with others, while 13% are not going to take it. Among those who are not going to take it, 25% stated that they would worry about other colleagues’ talk and opinions if they did not accept the vaccine.

Response among workers

The survey also measured employees’ acceptance of the vaccine in case it arrived at their workplace. According to the results, 62% of respondents are willing to take the vaccine and encourage others to take it, 25% will take it and will not interfere with others, while 13% are not going to take it. Among those who are not going to take it, 25% stated that they would worry about other colleagues’ talk and opinions if they did not accept the vaccine.

Share This Post
Share on facebook
Share on twitter
Share on linkedin

Related Articles